US Patent 7138501 Antibodies that immunospecifically bind BLyS
Patent 7138501 was granted and assigned to Human Genome Sciences on November, 2006 by the United States Patent and Trademark Office.
All edits
The present invention relates to antibodies and related molecules that immunospecifically bind to B Lymphocyte Stimulator. The present invention also relates to methods and compositions for detecting or diagnosing a disease or disorder associated with aberrant B Lymphocyte Stimulator expression or inappropriate function of B Lymphocyte Stimulator comprising antibodies or fragments or variants thereof or related molecules that immunospecifically bind to B Lymphocyte Stimulator. The present invention further relates to methods and compositions for preventing, treating or ameliorating a disease or disorder associated with aberrant B Lymphocyte Stimulator expression or inappropriate B Lymphocyte Stimulator function comprising administering to an animal an effective amount of one or more antibodies or fragments or variants thereof or related molecules that immunospecifically bind to B Lymphocyte Stimulator.
US Patent 07138501 Antibodies that immunospecifically bind BLyS US Patent 7138501 Antibodies that immunospecifically bind BLyS
US Patent 07138501 Antibodies that immunospecifically bind BLyS
Find more entities like US Patent 7138501 Antibodies that immunospecifically bind BLyS
